Chronobiology of Bipolar Disorder: Therapeutic Implication

Current Psychiatry Reports

Volumn 17, Issue 8, 2015, Pages

  Dallaspezia, Sara ^a   Benedetti, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Chronotherapeutic; Circadian rhythms; Clock genes; Lithium salts; Sleep; Sleep deprivation

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM SALT; MELATONIN; PROLACTIN; TRANSCRIPTION FACTOR ARNTL; TRANSCRIPTION FACTOR CLOCK; VALPROIC ACID; LITHIUM DERIVATIVE; TRANQUILIZER;

ARNTL GENE; BIPOLAR DISORDER; BODY TEMPERATURE; CIRCADIAN RHYTHM; CLOCK GENE; COGNITIVE DEFECT; COMORBIDITY; CSNK1 EPSILON GENE; DISEASE MODEL; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GSK 3 BETA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; MANIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PER3 GNE; PHENOTYPE; REV ERB GENE; REVIEW; RORA GENE; RORB GENE; SLEEP DEPRIVATION; SLEEP PATTERN; SLEEP QUALITY; TIM GENE; BIOLOGICAL RHYTHM; CHRONOPHARMACOLOGY; CHRONOTHERAPY; DRUG EFFECTS; GENETIC POLYMORPHISM; GENETICS; INFLAMMATION; MILD COGNITIVE IMPAIRMENT; MOOD DISORDER; PATHOPHYSIOLOGY; SLEEP;

ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIOLOGICAL CLOCKS; BIPOLAR DISORDER; CHRONOTHERAPY; CIRCADIAN RHYTHM; DRUG CHRONOTHERAPY; HUMANS; INFLAMMATION; LITHIUM COMPOUNDS; MILD COGNITIVE IMPAIRMENT; MOOD DISORDERS; POLYMORPHISM, GENETIC; SLEEP;

EID: 84932597723     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-015-0606-9     Document Type: Review

References (136)

1. McClung CA. How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry. 2013;74:242–9. This review summarizes recent data implicating the circadian system as a vital regulator of a variety of systems that are thought to play a role in the development of mood disorders.
2. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165:820–9.
3. Singh I, Rose N. Biomarkers in psychiatry. Nature. 2009;460:202–7.
4. Geoffroy PA, Bellivier F, Scott J, Etain B. Seasonality and bipolar disorder: a systematic review, from admission rates to seasonality of symptoms. J Affect Disord. 2014;168:210–23.
5. Mitterauer B. Clock genes, feedback loops and their possible role in the etiology of bipolar disorders: an integrative model. Med Hypotheses. 2000;55:155–9.
6. McClung CA. Role for the Clock gene in bipolar disorder. Cold Spring Harb Symp Quant Biol. 2007;72:637–44.
7. Klein DC, Moore RY, Reppert SM. Suprachiasmatic nucleus: the mind’s Clock. 1991.
8. Reischl S, Kramer A. Kinases and phosphatases in the mammalian circadian clock. FEBS Lett. 2011;585:1393–9.
9. Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet. 2000;34:533–62.
10. Moore RY, Lenn NJ. A retinohypothalamic projection in the rat. J Comp Neurol. 1972;146:1–14.
11. Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythm. 2006;21:494–506.
12. Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron. 2012;74:246–60.
13. Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal resetting cue for mammalian circadian oscillators. Science. 2010;330:379–85.
14. Avery D, Wildschiodtz G, Rafaelsen O. REM latency and temperature in affective disorder before and after treatment. Biol Psychiatry. 1982;17:463–70.
15. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry. 2004;184:496–502.
16. Deshauer D, Duffy A, Alda M, Grof E, Albuquerque J, Grof P. The cortisol awakening response in bipolar illness: a pilot study. Can J Psychiatry. 2003;48:462–6.
17. Havermans R, Nicolson NA, Berkhof J, de Vries MW. Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder. Psychoneuroendocrinology. 2011;36:258–65.
18. Ellenbogen MA, Santo JB, Linnen AM, Walker CD, Hodgins S. High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling. Bipolar Disord. 2010;12:77–86.
19. Cervantes P, Gelber S, Kin FN, Nair VN, Schwartz G. Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci. 2001;26:411–6.
20. Nurnberger Jr JI, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 2000;57:572–9.
21. Lewy AJ, Wher T, Gold PW, Goodwin FK. Plasma melatonin in manic depressive illness. In: Usdin E, Koping IJ, Barchas JD, editors. Catecholamines: basic and clinical frontiers. Oxford: Pergamon Press; 1979. p. 1173–5.
22. Kennedy SH, Tighe S, McVey G, Brown GM. Melatonin and cortisol “switches” during mania, depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis. 1989;177:300–3.
23. Novakova M, Prasko J, Latalova K, Sladek M, Sumova A. The circadian system of patients with bipolar disorder differs in episodes of mania and depression. Bipolar Disord. 2014.
24. Beck-Friis J, Ljunggren JG, Thoren M, von Rosen D, Kjellman BF, Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology. 1985;10:173–86.
25. Kennedy SH, Kutcher SP, Ralevski E, Brown GM. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res. 1996;63:219–22.
26. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Rosenthal NE. Manic-depressive patients may be supersensitive to light. Lancet. 1981;1:383–4.
27. Nathan PJ, Burrows GD, Norman TR. Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology. 1999;21:408–13.
28. Lewy AJ, Nurnberger Jr JI, Wehr TA, Pack D, Becker LE, Powell RL, et al. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry. 1985;142:725–7.
29. Nurnberger Jr JI, Berrettini W, Tamarkin L, Hamovit J, Norton J, Gershon E. Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology. 1988;1:217–23.
30. Linkowski P, Van Cauter E, L’Hermite-Baleriaux M, Kerkhofs M, Hubain P, L’Hermite M, et al. The 24-hour profile of plasma prolactin in men with major endogenous depressive illness. Arch Gen Psychiatry. 1989;46:813–9.
31. Fava GA, Molnar G, Spinks M, Loretan A, Edwards L, Morphy MA. Case report of prolactin and bipolar illness: a longitudinal study. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9:451–7.
32. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab. 1985;61:429–38.
33. Mendlewicz J, Linkowski P, Kerkhofs M, Desmedt D, Golstein J, Copinschi G, et al. Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab. 1985;60:505–12.
34. Gruber J, Miklowitz DJ, Harvey AG, Frank E, Kupfer D, Thase ME, et al. Sleep matters: sleep functioning and course of illness in bipolar disorder. J Affect Disord. 2011;134:416–20.
35. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry. 2008;165:830–43.
36. Jackson A, Cavanagh J, Scott J. A systematic review of manic and depressive prodromes. J Affect Disord. 2003;74:209–17.
37. Bauer M, Grof P, Rasgon N, Bschor T, Glenn T, Whybrow PC. Temporal relation between sleep and mood in patients with bipolar disorder. Bipolar Disord. 2006;8:160–7.
38. Jones SH, Tai S, Evershed K, Knowles R, Bentall R. Early detection of bipolar disorder: a pilot familial high-risk study of parents with bipolar disorder and their adolescent children. Bipolar Disord. 2006;8:362–72.
39. Duffy A, Alda M, Crawford L, Milin R, Grof P. The early manifestations of bipolar disorder: a longitudinal prospective study of the offspring of bipolar parents. Bipolar Disord. 2007;9:828–38.
40. Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ. Electroencephalographic sleep in mania. Arch Gen Psychiatry. 1988;45:267–73.
41. Linkowski P, Kerkhofs M, Rielaert C, Mendlewicz J. Sleep during mania in manic-depressive males. Eur Arch Psychiatry Neurol Sci. 1986;235:339–41.
42. Wehr TA, Sack DA, Norman E. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry. 1987;144:201–4.
43. Barbini B, Bertelli S, Colombo C, Smeraldi E. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res. 1996;65:121–5.
44. Rocha PM, Neves FS, Corrêa H. Significant sleep disturbances in euthymic bipolar patients. Compr Psychiatry. 2013;54(7):1003–8.
45. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 1997;42:209–12.
46. Perlman CA, Johnson SL, Mellman TA. The prospective impact of sleep duration on depression and mania. Bipolar Disord. 2006;8:271–4.
47. Duncan Jr WC, Pettigrew KD, Gillin JC. REM architecture changes in bipolar and unipolar depression. Am J Psychiatry. 1979;136:1424–7.
48. Riemann D, Voderholzer U, Berger M. Sleep and sleep-wake manipulations in bipolar depression. Neuropsychobiology. 2002;45 Suppl 1:7–12.
49. Sitaram N, Nurnberger Jr JI, Gershon ES, Gillin JC. Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder. Am J Psychiatry. 1982;139:571–6.
50. Geoffroy PA, Boudebesse C, Bellivier F, Lajnef M, Henry C, Leboyer M, et al. Sleep in remitted bipolar disorder: a naturalistic case–control study using actigraphy. J Affect Disord. 2014;158:1–7.
51. Gershon A, Thompson WK, Eidelman P, McGlinchey EL, Kaplan KA, Harvey AG. Restless pillow, ruffled mind: sleep and affect coupling in interepisode bipolar disorder. J Abnorm Psychol. 2012;121:863–73.
52. Eidelman P, Talbot LS, Gruber J, Hairston I, Harvey AG. Sleep architecture as correlate and predictor of symptoms and impairment in inter-episode bipolar disorder: taking on the challenge of medication effects. J Sleep Res. 2010;19:516–24.
53. McKenna BS, Eyler LT. Overlapping prefrontal systems involved in cognitive and emotional processing in euthymic bipolar disorder and following sleep deprivation: a review of functional neuroimaging studies. Clin Psychol Rev. 2012;32:650–63.
54. Canali P. A role for TMS/EEG in neuropsychiatric disorders. Neurol Psychiatry Brain Res. 2014;20:37–40.
55. Canali P, Sferrazza Papa G, Casali AG, Fecchio M, Pigorini A, Schiena G, et al. Changes of cortical excitability as biomarkers of antidepressant response in bipolar depression. Bipolar Disord. 2014;16:809–19. The first clinical trial investigating the circadian pattern of synaptic building during wake and downscaling during sleep in Bipolar Disorder by means of combined TMS/EEG, showing that lower cortical excitability predicts poor response to chronobiological treatments, which restore a normal circadian pattern of change of these measures in patients achieving the antidepressant response.
56. Boland EM, Alloy LB. Sleep disturbance and cognitive deficits in bipolar disorder: toward an integrated examination of disorder maintenance and functional impairment. Clin Psychol Rev. 2013;33:33–44.
57. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116:214–7.
58. Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104:91–5.
59. O’Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006;90:263–7.
60. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, et al. Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord. 2009;11:726–34.
61. Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen L, Beumer W, Versnel MA, et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother. 2010;10:59–76.
62. Manzar MD, Hussain ME. Sleep-immune system interaction: advantages and challenges of human sleep loss model. Front Neurol. 2012;3:2.
63. Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des. 2008;14:3408–16.
64. Dinges DF, Douglas SD, Zaugg L, Campbell DE, McMann JM, Whitehouse WG, et al. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest. 1994;93:1930–9.
65. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373–7. A pivotal preclinical trial showing that the intercellular space increases its water content during sleep, thus markedly increasing diffusion of neurotransmitters and other substances through the extracellular matrix and promoting the clearance of metabolites, including β-amyloid, from the brain.
66. Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368–73.
67. Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:234–41.
68. Mansour HA, Wood J, Logue T, Chowdari KV, Dayal M, Kupfer DJ, et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 2006;5:150–7.
69. Lee KY, Song JY, Kim SH, Kim SC, Joo EJ, Ahn YM, et al. Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1196–201.
70. Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R, et al. Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord. 2009;11:215–20.
71. Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, et al. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci Res. 2008;62:211–5.
72. Soria V, Martinez-Amoros E, Escaramis G, Valero J, Perez-Egea R, Garcia C, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology. 2010;35:1279–89.
73. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, et al. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry. 2009;9:70.
74. Ronai Z, Kovacs-Nagy R, Szantai E, Elek Z, Sasvari-Szekely M, Faludi G, et al. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2014;165B:217–22.
75. Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T, et al. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:259–65.
76. Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1047–55.
77. Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen-White KR, Rosso A, et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry. 2002;7:851–9.
78. Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep. 1998;21:569–76.
79. Serretti A, Cusin C, Benedetti F, Mandelli L, Pirovano A, Zanardi R, et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2005;10:10.
80. Benedetti F, Dallaspezia S, Fulgosi MC, Lorenzi C, Serretti A, Barbini B, et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:631–5.
81. Benedetti F, Serretti A, Colombo C, Barbini B, Lorenzi C, Campori E, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet. 2003;123B:23–6.
82. Benedetti F, Radaelli D, Bernasconi A, Dallaspezia S, Falini A, Scotti G, et al. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav. 2008;7:20–5.
83. Pawlak J, Dmitrzak-Weglarz M, Maciukiewicz M, Wilkosc M, Leszczynska-Rodziewicz A, Zaremba D, et al. Suicidal behavior in the context of disrupted rhythmicity in bipolar disorder-Data from an association study of suicide attempts with clock genes. Psychiatry Res. 2015;226:517–20.
84. Benedetti F, Dallaspezia S, Colombo C, Pirovano A, Marino E, Smeraldi E. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett. 2008;445:184–7.
85. Dallaspezia S, Lorenzi C, Pirovano A, Colombo C, Smeraldi E, Benedetti F. Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder. Eur Psychiatry. 2011;26:138–40.
86. Jimenez E, Arias B, Mitjans M, Goikolea JM, Roda E, Ruiz V, et al. Association between GSK3beta gene and increased impulsivity in bipolar disorder. Eur Neuropsychopharmacol. 2014;24:510–8.
87. Jimenez E, Arias B, Mitjans M, Goikolea JM, Roda E, Saiz PA, et al. Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol. 2013;23:1452–62.
88. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett. 2004;355:37–40.
89. Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett. 2004;368:123–6.
90. Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta −50 T/C SNP. Neurosci Lett. 2005;376:51–5.
91. Benedetti F, Bollettini I, Barberi I, Radaelli D, Poletti S, Locatelli C, et al. Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology. 2013;38:313–27.
92. Benedetti F, Poletti S, Radaelli D, Locatelli C, Pirovano A, Lorenzi C, et al. Lithium and GSK-3beta promoter gene variants influence cortical gray matter volumes in bipolar disorder. Psychopharmacology (Berl). 2015;232:1325–36.
93. McCarthy MJ, Nievergelt CM, Shekhtman T, Kripke DF, Welsh DK, Kelsoe JR. Functional genetic variation in the Rev-Erbalpha pathway and lithium response in the treatment of bipolar disorder. Genes Brain Behav. 2011;10:852–61.
94. Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A. 2013;110:9950–5.
95. Li SX, Liu LJ, Xu LZ, Gao L, Wang XF, Zhang JT, et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology. 2013;38:2789–99.
96. Sjoholm LK, Backlund L, Cheteh EH, Ek IR, Frisen L, Schalling M, et al. CRY2 is associated with rapid cycling in bipolar disorder patients. PLoS One. 2010;5, e12632.
97. Coyle JT. What can a clock mutation in mice tell us about bipolar disorder? Proc Natl Acad Sci U S A. 2007;104:6097–8.
98. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci. 2006;26:9022–9.
99. Abarca C, Albrecht U, Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc Natl Acad Sci U S A. 2002;99:9026–30.
100. Landgraf D, McCarthy MJ, Welsh DK. The role of the circadian clock in animal models of mood disorders. Behav Neurosci. 2014;128:344–59. A conceptual review of how animal models can be developed to investigate whether circadian rhythm disruptions alter mood, by using clock gene mutants, manipulations of sleep-wake and light–dark cycles, and brain lesions affecting clock function.
101. Nomura K, Castanon-Cervantes O, Davidson A, Fukuhara C. Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts. Life Sci. 2008;82:1169–74.
102. Sprouse J, Braselton J, Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry. 2006;60:896–9.
103. Prosser RA, Lee HM, Wehner A. Serotonergic pre-treatments block in vitro serotonergic phase shifts of the mouse suprachiasmatic nucleus circadian clock. Neuroscience. 2006;142:547–55.
104. Cuesta M, Mendoza J, Clesse D, Pevet P, Challet E. Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp Neurol. 2008;210:501–13.
105. Manev H, Uz T. Clock genes: influencing and being influenced by psychoactive drugs. Trends Pharmacol Sci. 2006;27:186–9.
106. Kripke DF, Wyborney VG. Lithium slows rat circadian activity rhythms. Life Sci. 1980;26:1319–21.
107. Welsh DK, Moore-Ede MC. Lithium lengthens circadian period in a diurnal primate. Saimiri sciureus. Biol Psychiatry. 1990;28:117–26.
108. Johnsson A, Engelmann W, Pflug B, Klemke W. Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int J Chronobiol. 1983;8:129–47.
109. Abe M, Herzog ED, Block GD. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport. 2000;11:3261–4.
110. Li J, Lu WQ, Beesley S, Loudon AS, Meng QJ. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One. 2012;7:e33292. A preclinical trial showing that lithium increases the oscillation amplitude of clock protein dynamics in the central and peripheral circadian clockwork, and it does it by inhibiting glycogen synthase kinase 3 beta, thus providing a link between classical research on the neuroscience of lithium and chronobiology.
111. Freland L, Beaulieu JM. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci. 2012;5:14.
112. Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci U S A. 2008;105:20746–51.
113. Vougogiannopoulou K, Ferandin Y, Bettayeb K, Myrianthopoulos V, Lozach O, Fan Y, et al. Soluble 3’,6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase −3 alter circadian period. J Med Chem. 2008;51:6421–31.
114. Kripke DF, Judd LL, Hubbard B, Janowsky DS, Huey LY. The effect of lithium carbonate on the circadian rhythm of sleep in normal human subjects. Biol Psychiatry. 1979;14:545–8.
115. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science. 2006;311:1002–5.
116. Gould TD, Manji HK. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005;30:1223–37.
117. Hallam KT, Olver JS, Horgan JE, McGrath C, Norman TR. Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers. Int J Neuropsychopharmacol. 2005;8:255–9.
118. Johansson AS, Brask J, Owe-Larsson B, Hetta J, Lundkvist GB. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J Biol Rhythm. 2011;26:541–51.
119. Klemfuss H, Kripke DF. Antimanic drugs stabilize hamster circadian rhythms. Psychiatry Res. 1995;57:215–22.
120. Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry. 2004;9:1007–29.
121. Hallam KT, Olver JS, Norman TR. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neuropsychopharmacology. 2005;30:1400–4.
122. Niles LP, Sathiyapalan A, Bahna S, Kang NH, Pan Y. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int J Neuropsychopharmacol. 2012;15:1343–50.
123. Dallaspezia S, Benedetti F. Chronobiological therapy for mood disorders. Expert Rev Neurother. 2011;11:961–70.
124. Benedetti F. Antidepressant chronotherapeutics for bipolar depression. Dialogues in Clinical Neuroscience. 2012;14:401–11.
125. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry. 1999;46:445–53.
126. Wirz-Justice A, Terman M, Oren DA, Goodwin FK, Kripke DF, Whybrow PC, et al. Brightening depression. Science. 2004;303:467–9.
127. Benedetti F, Smeraldi E. Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development. Curr Pharm Des. 2009;15:2637–49.
128. Dallaspezia S, Benedetti F. Sleep deprivation therapy for depression. Curr Top Behav Neurosci. 2015;25:483–502. A recent review about sleep deprivation therapy focusing on both clinical and biological aspects.
129. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 2005;66:1535–40.
130. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res. 2000;95:43–53.
131. Wehr TA, Sack DA, Norman E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry. 1998;43:822–8.
132. Terman M. Evolving applications of light therapy. Sleep Med Rev. 2007;11:497–507.
133. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10:647–63. quiz 72.
134. Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, et al. Dark therapy for mania: a pilot study. Bipolar Disord. 2005;7:98–101.
135. Slat E, Freeman GM, Jr., Herzog ED. The clock in the brain: neurons, glia, and networks in daily rhythms. Handb Exp Pharmacol. 2013;217:105–23.
136. Benedetti F, Terman M. Much ado about…a moody clock. Biol Psychiatry. 2013;74:236–7.